3 Forgotten AI Stocks That Should Rebound From Their Corrections

Penguin Solutions posted 48% year-over-year fiscal Q3 2026 revenue growth, while its Integrated Memory segment, including CXL products for AI infrastructure, more than doubled and reached 57.5% of sales. MaxLinear's Q2 revenue rose 55% year over year and 23% sequentially, with Q3 midpoint guidance of $215 million implying another 27% sequential increase; management expects multiple AI data-center growth drivers to persist for at least two years. Aehr Test Systems forecasts fiscal 2027 revenue of $130 million-$150 million versus $50 million in fiscal 2026, supported by a $22 million follow-on AI processor test-equipment order, although its $3 billion valuation remains elevated.

Analysis

The investable distinction is where each company sits in the AI capex stack. MXL has the cleanest near-term operating leverage because optical interconnect content rises with cluster scale and speed transitions; incremental revenue should carry materially higher gross margin than its legacy broadband mix. The key 1-3 month catalyst is whether bookings and design-win commentary support another sequential step-up beyond guided revenue, which would justify further multiple expansion despite the sharp share-price move.

PENG is more nuanced than a pure CXL semiconductor exposure: it is exposed to enterprise qualification cycles, system integration execution, and the pace at which customers adopt CXL memory pooling rather than simply buy HBM. That can create a favorable mix shift over 6-18 months, but it also means reported growth may not translate one-for-one into margin expansion. A successful CXL deployment cycle is potentially negative for portions of the premium-memory ecosystem, including suppliers reliant on ever-higher HBM content per accelerator, although CXL is more likely complementary than substitutive in the near term.

AEHR has the least forgiving setup. Its valuation embeds conversion of hyperscaler interest into repeatable production orders, while burn-in/test demand is inherently concentrated and subject to customer qualification timing; one delayed platform ramp can create an outsized revenue and multiple reset. Consensus appears to be extrapolating AI-package complexity without adequately discounting the lumpy capital-equipment model. The thesis is falsified positively by backlog visibility and multiple customer production wins, and negatively by a guide below the stated fiscal revenue range or a material rise in receivables/inventory without bookings support.

Contrarian view: the more durable beneficiary of AI cluster scaling may be connectivity rather than niche memory architectures or test capacity, since network intensity rises even if accelerator unit demand normalizes. Favor MXL only if the next earnings release confirms optical growth is broad-based rather than one or two customer programs; otherwise, these names remain momentum vehicles rather than fundamental compounders.

Key Decisions for Investors

• Initiate a modest long MXL position over the next 1-2 weeks, preferably on post-rally consolidation; target a 15-25% upside over 3-6 months if optical-data-center revenue sustains sequential growth, with a 10-12% stop or exit on a Q4 guide that breaks the current growth trajectory.
• Use a pair structure: long MXL / short AEHR in equal dollar risk for a 3-6 month horizon. This expresses preference for recurring connectivity content over a high-multiple, order-lumpy test-equipment story; cover the AEHR short if disclosed backlog or production orders demonstrate diversified hyperscaler demand.
• Keep PENG on a qualification watch rather than chase current momentum. Upgrade to a long only after management discloses CXL customer concentration, gross-margin progression, and evidence of repeat deployments; a failure of Integrated Memory mix to produce consolidated margin expansion over the next two reports would invalidate the rerating case.
• For existing AEHR longs, reduce exposure into strength or collar the position ahead of the next guidance update. The relevant downside trigger is not modest revenue volatility but evidence that fiscal targets rely on a single customer program; that scenario could drive a 30%+ multiple compression from an already elevated revenue valuation.